Dr. Hallberg was an internationally recognized leader in nutritional management of type 2 diabetes (T2D) and other metabolic diseases. She founded the Indiana University Health Arnett’s Medically Supervised Weight Loss Program, and was the primary investigator for the largest and longest ever clinical trial examining a nonsurgical intervention for the reversal of T2D.
Dr. Hallberg’s research had far-reaching implications for public health. Her work was cited by the American Diabetes Association (ADA) Standards of Care for Diabetes in 2019 and 2020, and in the 2019 Nutrition Recommendation Consensus paper published when ADA guidelines were changed to endorse low-carbohydrate eating patterns.
Dr. Hallberg passed away in March 2022 after battling cancer since 2017. She was open about having stage IV lung cancer despite being a nonsmoker, and published a touching blog in 2020 detailing her experience as a wife, mother, and cancer patient amid the COVID-19 pandemic. She was a pioneer in metabolic conditions such as T2D, and is greatly missed by Cardiometabolic Health Congress and the entire medical community.